(Q34280107)

1 August 2017

2 references

7 November 2019

14 August 2023

1 reference

title

Do prescription stimulants increase the risk of adverse cardiovascular events?: A systematic review (English)

1 reference

attention deficit hyperactivity disorder

1 August 2017

main subject

1 reference

7 November 2019

1 reference

17 June 2019

myocardial infarction

1 reference

7 November 2019

1 reference

7 November 2019

1 reference

7 November 2019

1 reference

2

Ethan A Halm

1 reference

1 August 2017

1

Arthur N Westover

1 reference

1 August 2017

language of work or name

1 reference

9 June 2012

9 references

BMC Cardiovascular Disorders

1 August 2017

13 March 2019

14 March 2019

19 March 2019

22 March 2019

25 April 2019

17 June 2019

7 November 2019

14 August 2023

9 references

1 August 2017

13 March 2019

14 March 2019

19 March 2019

22 March 2019

25 April 2019

17 June 2019

7 November 2019

14 August 2023

12

1 reference

1 August 2017

page(s)

41

1 reference

Creative Commons Attribution 2.0 Generic

1 August 2017

copyright license

8 references

13 March 2019

14 March 2019

19 March 2019

22 March 2019

25 April 2019

17 June 2019

7 November 2019

on focus list of Wikimedia project

14 August 2023

copyright status

copyrighted

0 references

ScienceSource

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/1471-2261-12-41

0 references

cites work

Methylphenidate and risk of serious cardiovascular events in adults.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405448

Stimulants and cardiovascular events in youth with attention-deficit/hyperactivity disorder

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405448

ADHD medications and risk of serious cardiovascular events in young and middle-aged adults.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405448

ADHD drugs and serious cardiovascular events in children and young adults

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405448

Cardiovascular events and death in children exposed and unexposed to ADHD agents

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405448

Food and Drug Administration recommends against the continued use of propoxyphene

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405448

Atomoxetine and cerebrovascular outcomes in adults

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405448

Cardiac safety of methylphenidate versus amphetamine salts in the treatment of ADHD.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405448

Methylphenidate for the treatment of depressive symptoms, including fatigue and apathy, in medically ill older adults and terminally ill adults

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405448

Drugs of abuse that mediate advanced glycation end product formation: a chemical link to disease pathology

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405448

Potential adverse effects of amphetamine treatment on brain and behavior: a review

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405448

Self-vaccination by methamphetamine glycation products chemically links chronic drug abuse and cardiovascular disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405448

Methamphetamine and cardiovascular pathology: a review of the evidence

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405448

Therapeutic advances in narcolepsy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405448

Methamphetamine-associated acute myocardial infarction and cardiogenic shock with normal coronary arteries: refractory global coronary microvascular spasm.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405448

Spontaneous multivessel coronary vasospasm leading to cardiogenic shock

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405448

Disorders of speech and language: aphasia, apraxia and dysarthria

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405448

Monoaminergic agonists for acute traumatic brain injury

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405448

ADHD drugs and cardiovascular risk

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405448

Is prehypertension a risk factor for cardiovascular diseases?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405448

Immunological consequences of methamphetamine protein glycation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405448

Lacunar stroke associated with methylphenidate abuse

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405448

Drug induced QT prolongation and torsades de pointes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405448

Cardiovascular effects of atomoxetine in children, adolescents, and adults

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405448

Impact of high-normal blood pressure on the risk of cardiovascular disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405448

Cerebral arteritis following methylphenidate use.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405448

Vasculitis owing to substance abuse

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405448

Intracerebral hemorrhage and angiographic beading following amphetamine abuse

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405448

Cerebral arteritis and oral methylphenidate

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405448

Cocaine- and methamphetamine-induced acute cerebral vasospasm: an angiographic study in rabbits

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405448

Cerebral microvascular injury in experimental drug abuse

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405448

Plasma levels of d-amphetamine in hyperactive children. Serial behavior and motor responses

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405448

Trends in medication treatment for ADHD.

6 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-41

Stimulant dosing in the community treatment of adult attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-41

Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-41

A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-41

Effect of stimulants on 24-h ambulatory blood pressure in children with ADHD: a double-blind, randomized, cross-over trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-41

Short-term cardiovascular effects of methylphenidate and adderall

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-41

24-hour ambulatory blood pressure monitoring in male children receiving stimulant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-41

Methamphetamine-induced myocardial infarction with elevated troponin I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-41

Acute myocardial infarction related to methylphenidate for adult attention deficit disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-41

Myocardial infarction in an adolescent taking Adderall

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-41

Delayed ischemic stroke associated with methamphetamine use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-41

Electrocardiographic abnormalities in methamphetamine abusers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-41

From "prehypertension" to hypertension? Additional evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-41

Acute myocardial infarction in a young male on methylphenidate, bupropion, and erythromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-41

Impact of the American Heart Association scientific statement on screening electrocardiograms and stimulant medications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-41

Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-41

Mortality associated with attention-deficit hyperactivity disorder (ADHD) drug treatment: a retrospective cohort study of children, adolescents and young adults using the general practice research database

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-41

Sudden death and use of stimulant medications in youths.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-41

American Academy of Pediatrics/American Heart Association clarification of statement on cardiovascular evaluation and monitoring of children and adolescents with heart disease receiving medications for ADHD: May 16, 2008.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405448

Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405448

Datapoints: trends in ADHD and stimulant use among adults: 1995-2002

28 October 2018

1 reference

12 December 2020

1 reference

12 December 2020

A double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder

1 reference

12 December 2020

Amphetamine-associated ischemic stroke: clinical presentation and proposed pathogenesis

1 reference

12 December 2020

Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder [corrected]: a scientific statement from the American Heart Association Council on Cardiovascular Disease in

1 reference

12 December 2020

Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Cardiovascular risk screening before starting stimulant medications and prescribing practices of canadian physicians: impact of the Health Canada advisory

1 reference

12 December 2020

Association between blood pressure level and the risk of myocardial infarction, stroke, and total mortality: the cardiovascular health study

1 reference

12 December 2020

Necrotizing angiitis associated with drug abuse

1 reference

12 December 2020

Cerebral angiographic changes in the drug abuse patient

1 reference

12 December 2020

Cerebral Vascular Changes Secondary to Amphetamine Abuse in the Experimental Animal

1 reference

12 December 2020

Amphetamine induced cerebral vasculitis

1 reference

12 December 2020

Intracerebral hemorrhage and vasculitis related to ephedrine abuse

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2261-12-41

1 reference

Dimensions Publication ID

1 August 2017

0 references

1 reference

1 August 2017

1 reference